CDK2/PIM1-IN-1
CDK2/PIM1-IN-1 is an inhibitor of CDK2 (IC50: 0.27 μM) and PIM1 (IC50: 0.67 μM) kinases. CDK2/PIM1-IN-1 induces apoptosis and reduces tumor-promoting TNF-α expression. CDK2/PIM1-IN-1 has antitumor activity[1].
Product Specifications
UNSPSC
12352005
Target
CDK; Pim
Related Pathways
Cell Cycle/DNA Damage; JAK/STAT Signaling
Field of Research
Cancer
Smiles
COC1=CC=C(C2=CC=NC3=C2C(C4=CC=C(C)C=C4)=NN3C5=CC=CC=C5)C=C1OC
Molecular Formula
C27H23N3O2
Molecular Weight
421.49
References & Citations
[1]Elkotamy MS, et al. Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity. J Biomol Struct Dyn. 2025 Mar 13:1-25.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; PIM1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C52018-500MG 1 Unit
2-Propynyl 2-acetamido-2-deoxy-α-D-glucopyranoside
Sign In for Pricing
View Details ![Rabbit Polyclonal dystrophia myotonica containing WD repeat motif Antibody [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP3-30748B 0.1 mL
Rabbit Polyclonal dystrophia myotonica containing WD repeat motif Antibody [Biotin]
Sign In for Pricing
View Details